Fred Telling insider trades: Oragenics (OGEN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Fred reports to the SEC
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | OGEN | ↓ Sell | 210 | $0.94 | $198 | Direct | Jan 22, 2026 (41d) |
| Dec 12, 2025 | OGEN | ↓ Sell | 210 | $0.94 | $198 | Direct | Dec 15, 2025 (3d) |
| Dec 6, 2024 | OGEN | ↓ Sell | 3,597 | $0.36 | $1K | Direct | Dec 9, 2024 (3d) |
| Nov 30, 2023 | OGEN | ↓ Sell | 3,500 | $3.57 | $12K | Direct | Dec 1, 2023 (1d) |
| Jun 17, 2022 | OGEN | ↑ Buy | 10,084 | $0.29 | $3K | Direct | Jun 21, 2022 (4d) |
| May 24, 2022 | OGEN | ↑ Buy | 82,173 | $0.29 | $24K | Direct | May 25, 2022 (1d) |
| May 20, 2022 | OGEN | ↑ Buy | 65,718 | $0.28 | $19K | Direct | May 23, 2022 (3d) |
| May 19, 2022 | OGEN | ↑ Buy | 72,109 | $0.28 | $20K | Direct | May 20, 2022 (1d) |
| Mar 31, 2022 | OGEN | ↑ Buy | 183,838 | $0.36 | $66K | Direct | Apr 1, 2022 (1d) |
| Nov 24, 2020 | OGEN | ↑ Buy | 100,000 | $0.37 | $37K | Direct | Nov 25, 2020 (1d) |
| Jun 30, 2016 | OGEN.BC | ↑ Buy | 969,180 | $0.52 | $500K | Direct | Jul 1, 2016 (1d) |
| Nov 14, 2014 | OGEN | ↑ Buy | 27,000 | $0.95 | $26K | Direct | Nov 17, 2014 (3d) |
| Mar 7, 2014 | CTIC | ↓ Sell | 72,095 | $3.75 | $271K | Direct | Mar 7, 2014 (0d) |
| May 30, 2013 | CTIC | ↓ Sell | 64,798 | $1.24 | $80K | Direct | May 31, 2013 (1d) |
| Sep 18, 2012 | CTIC | ↓ Sell | 18,874 | $2.86 | $54K | Direct | Sep 20, 2012 (2d) |
| Jul 31, 2012 | ORNI | ↑ Buy | 98,111 | $1.50 | $147K | Direct | Aug 2, 2012 (2d) |
| Aug 25, 2011 | ORNI | ↑ Buy | 6,460 | $2.39 | $15K | Direct | Aug 29, 2011 (4d) |
| Aug 23, 2011 | ORNI | ↑ Buy | 3,540 | $2.26 | $8K | Direct | Aug 24, 2011 (1d) |
| Nov 5, 2010 | CTIC | ↓ Sell | 216,016 | $0.39 | $84K | Direct | Nov 8, 2010 (3d) |
| Jun 29, 2010 | CTIC | ↓ Sell | 105,823 | $0.42 | $44K | Direct | Jul 1, 2010 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Fred Telling's insider trades
Fred Telling is a director at Oragenics (OGEN). Since Jun 29, 2010, Fred has reported 11 open-market purchases worth $864K and 9 sales worth $547K on SEC Form 4. In the last 12 months: 2 sales ($397).
Their filings also include grants and awards (54 filings), option exercises (3 filings), other transactions (3 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OGEN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.